# EDGAR Filing Document

**Accession Number:** 0001766016
**File Stem:** 0001766016-25-000006
**Filing Date:** 2025-11
**Character Count:** 9579
**Document Hash:** f45eeec85a36bad2e887938b4f0dc67f
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001766016-25-000006.hdr.sgml**: 20251118

**ACCESSION NUMBER**: 0001766016-25-000006

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20251118

**ITEM INFORMATION**: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

**ITEM INFORMATION**: Other Events

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20251118

**DATE AS OF CHANGE**: 20251118

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Crucial Innovations, Corp.
- **CENTRAL INDEX KEY:** 0001766016
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-EDUCATIONAL SERVICES [8200]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 333-229638
- **FILM NUMBER:** 251494255

**BUSINESS ADDRESS:**
- **STREET 1:** 122 LEADENHALL STREET, 30TH FLOOR
- **CITY:** LONDON
- **STATE:** X0
- **ZIP:** EC3V 4AB
- **BUSINESS PHONE:** 44(0)207-043-1541

**MAIL ADDRESS:**
- **STREET 1:** 122 LEADENHALL STREET, 30TH FLOOR
- **CITY:** LONDON
- **STATE:** X0
- **ZIP:** EC3V 4AB

**___________________________________________**

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**FORM 8-K**

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 12, 2025

**CRUCIAL INNOVATIONS CORP.**

(Exact Name of Registrant as Specified in its Charter)

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;**Nevada** | &nbsp;&nbsp; **333-229638** | &nbsp;&nbsp;**98-1446012** |
| &nbsp;&nbsp;(State or Other Jurisdiction | &nbsp;&nbsp;(Commission File | &nbsp;&nbsp;(IRS Employer |
| &nbsp;&nbsp;Of Incorporation) | &nbsp;&nbsp;Number) | &nbsp;&nbsp;Identification No.) |

---

---

| | |
|:---|:---|
| &nbsp;&nbsp; <br> **86-90 Paul Street**<br> **London, United Kingdom** | &nbsp;&nbsp; <br>**EC2A 4NE** |
| &nbsp;&nbsp;(Address of Principal Executive Offices) | &nbsp;&nbsp;(Zip Code) |

---

**Registrant's telephone number, including area code: +44 (0) 203 148 1452**

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-k filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

---

| | |
|:---|:---|
| **Item 5.02** | **Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.** |

---

On November 12, 2025, Timothy Ambrose resigned from his service on the Board of Directors ("Board") of Crucial Innovations Corp. (the "Company") and also resigned from his service as an executive officer of the Company. Mr. Ambrose was appointed to the Board and as an executive officer of the Company on October 17, 2021.

Also on November 12, 2025, the Board appointed Rory J. Bowen as an independent director to fill the vacancy on the Board resulting from the resignation of Mr. Ambrose, to serve until the next annual meeting of the Company's shareholders. Other than the foregoing, there are no arrangements or understandings between Mr. Bowen and any other person pursuant to which Mr. Bowen was selected as a director.

Rory J. Bowen, age 36, is currently the Chief of Staff at Hermitage Holdings, a global investment company. He is also a Founder and Principal of Circus Capital, Principal at Outsize Capital, both corporate finance advisory firms, and a non-executive director of Kadoma Mining PLC. Prior to his appointment to the Board, Mr. Bowen served as a strategy consultant to the Company, and previously served as Chief of Staff for the Fintech Alliance in London from April 2019 through April 2020, and Agri-Fintech Holdings, Inc. from April 2021 through December 2023. Mr. Bowen has also served in a number of advisory roles for a variety of multinational companies in the financial services, agri-tech, commodities, and media sectors.

---

| | |
|:---|:---|
| **Item 8.01** | **Other Events.** |

---

On November 18, 2025, the Company issued a press release announcing the appointment of Mr. Bowen described in Item 5.02 above. The text of the press release is included as Exhibit 99.1 to this Current Report and is incorporated herein by reference.

---

| | |
|:---|:---|
| **Item 9.01** | **Financial Statements and Exhibits.** |

---

**(d) Exhibits.**

[99.1 Press release issued on November 18, 2025.](ex991_pressrelease.htm)

<u>SIGNATURES</u>

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | |
|:---|:---|
|  | **CRUCIAL INNOVATIONS CORP.** |
| Date: November 18, 2025 |  |
| By: | &nbsp;&nbsp;&nbsp;&nbsp;/s/ Jon-Paul Doran |
| Name: | **Jon-Paul Doran** |
| Title: | **Chief Executive Officer** |

---

## Exhibit 99.1

[EXHIBIT 99.1](f8k_cinv11122025.htm)

**Crucial Innovations Corp. Appoints Rory Bowen to its Board of Directors** **<br>** <br> *Seasoned finance and innovation executive brings global strategy and governance expertise to support CINV's mission of advancing medicinal cannabis accessibility across the UK and Europe*

**LONDON (Nov. 18, 2025) — Crucial Innovations Corp.**, a pioneering medical cannabis company, announced the appointment of Rory Bowen to its Board of Directors, effective immediately.

Mr. Bowen is a seasoned executive, investor and strategist with extensive experience spanning finance, technology and global innovation. He currently serves as Chief of Staff at Hermitage Holdings, a global investment company; Principal and Founder of Circus Capital; Principal at Outsize Capital; and Non-Executive Director at Kadoma Mining PLC.

With a proven track record of driving strategic growth and organizational transformation, Mr. Bowen brings multidisciplinary expertise in corporate finance, capital markets and governance. He has worked alongside CEOs, boards and senior leadership teams to implement high-impact operational frameworks that balance innovation with disciplined execution.

"Rory's appointment reflects our commitment to bringing visionary, globally minded leaders onto our Board," said Crucial Innovations Corp. CEO JP Doran. "His deep understanding of capital markets, strategic partnerships and international business development will strengthen CINV's mission to advance the accessibility and integrity of cannabis-based medicines across the UK and Europe."

Adding Rory to the Board as an independent director is reflective of the Company's intention to meet Nasdaq's corporate governance standards by having a majority of independent directors on the Board.

Mr. Bowen began his career in financial markets with Moneycorp and Compagnie Financière Tradition (Tradition UK), before transitioning into strategic leadership at FinTech Alliance, an organization established in partnership with the UK Department for International Trade. There, he helped shape the UK's national FinTech growth and investment agenda, representing the British Government on international trade missions and engaging with global policymakers.

His subsequent leadership roles across Europe, Africa and the Middle East have provided him with deep cross-cultural insight into emerging markets, M&A strategy and regulatory navigation—skills that will contribute significantly to CINV's evolving international footprint.

"Crucial Innovations is setting new standards for the cultivation and delivery of cannabis-based products for medicinal use," said Bowen. "I am honoured to join the Board at this pivotal moment and look forward to supporting the company's mission to deliver safe, effective and ethically produced Cannabis-Based Products for Medicinal Use (CBPMs) through a truly global seed-to-heal model."

**About Crucial Innovations Corp. (CINV)**<br> Crucial Innovations Corp. (OTC: CINV) is a pioneering medical cannabis company. With a fully licensed network of esteemed cultivators, CINV delivers carefully curated cannabis to the medicinal market in the UK and Europe through its vertically integrated seed-to-sale process. At CINV, we are establishing a new standard for cultivating high-quality cannabis-based products for medicinal use (CBPMs), ensuring consistency, safety, and accessibility across the global supply chain. For more information, please visit www.cinvcorp.com.

**Media Contact:**<br> cinv@kcsa.com